Skip to main content

Day: April 3, 2025

Abcourt Closes Initial Tranche Non-Brokered Private Placement for Gross Proceeds of $1,668,040

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ROUYN-NORANDA, Quebec, April 03, 2025 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB: ABMBF) is pleased to announce that it has closed a first tranche of its previously announced non-brokered private, for gross proceeds of $1,668,040 (the “Offering”) from the sale of the following:2,300,000 units of the Corporation (the “Units”) at a price of $0.05 per Unit for gross proceeds $115,000 from the sale of Units; and 25,884,000 common shares of the Corporation that qualify as “flow-through shares” within the meaning of subsection 66(15) of the Income Tax Act (Canada) and section 359.1 of the Taxation Act (Québec) (each, a “FT Share”) at a price of $0.06 per FT Share for gross proceeds of $1,553,040...

Continue reading

Mesoblast Allogeneic Cell Therapy Products Are Designated ‘U.S. Country of Origin’ and Not Subject to U.S. Tariffs

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) — Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the status of its products in relation to the U.S. Government’s announcement on tariffs for imported products. Mesoblast believes that its allogeneic cellular products, including Ryoncil® and Revascor®, will not be subject to the tariffs. Mesoblast develops allogeneic products based on its proprietary remestemcel-L and rexlemestrocel-L mesenchymal lineage stromal and precursor cell platform technologies. Its allogeneic cellular products derived from these platforms are manufactured from U.S. donors in the U.S. and designated as U.S. origin products. Ryoncil® (remestemcel-L) is the only allogeneic mesenchymal stromal cell therapy approved by U.S. Food...

Continue reading

Texas Capital Bancshares, Inc. Announces Date for Q1 2025 Operating Results

DALLAS, April 03, 2025 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the first quarter of 2025 before market on Thursday, April 17, 2025. Executive management will host a conference call and webcast to discuss first quarter 2025 operating results on Thursday, April 17, 2025, at 9:00 a.m. EDT. Participants may pre-register for the call by visiting https://www.netroadshow.com/events/login?show=c5d392d2&confId=80603 and will receive a unique PIN number to be used when dialing in for the call for immediate access. Alternatively, participants may call 833.470.1428 and use the access code 580174 at least fifteen minutes prior to the call to join through an operator. The live webcast can be found at https://events.q4inc.com/attendee/299753902....

Continue reading

Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting

Oral Plenary Presentation on Tuesday, April 8 Features Phase 3 Data for ANX005, the First Potential Targeted Therapy for GBS, Showing Rapid and Durable Benefit Across Clinical Measures and Time Points Educational Symposium Focuses on Advancing GBS Care and Role of Classical Complement Pathway New Disease Education Campaign “Move GBS Forward” Draws Attention to Life-altering Physical and Mental Impact of GBS BRISBANE, Calif., April 03, 2025 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today highlights the company’s leadership in advancing clinical research and education for GBS at the AAN Annual Meeting taking place April...

Continue reading

Anne Whitaker Appointed as Non-Executive Director

MELBOURNE, Australia and INDIANAPOLIS, April 04, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces the appointment of Anne Whitaker as a Non-Executive Director (NED) based in the United States, effective 7 April 20251. Ms. Whitaker is a seasoned healthcare leader and advisor with over 30 years’ global corporate experience spanning large pharmaceutical, biotech and speciality pharmaceutical companies, including clinical research and manufacturing organizations. She has held Board positions on a range of Nasdaq-listed clinical and commercial stage life sciences companies. Ms. Whitaker is currently serving as a NED at Icon PLC (NASDAQ: ICLR) and is Chair at QurAlis Corporation. Ms. Whitaker is an accomplished C-suite leader, most recently as Chair and CEO of Aerami Therapeutics...

Continue reading

LGI Homes Reports March and First Quarter 2025 Home Closings and Announces Date for First Quarter Earnings Conference Call

THE WOODLANDS, Texas, April 03, 2025 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 426 homes in March 2025. The Company closed 996 homes during the first quarter of 2025. As of March 31, 2025, the Company had 146 active selling communities. First Quarter 2025 Earnings Conference Call and Webcast The Company plans to release financial results for the first quarter ended March 31, 2025, before the market opens on Tuesday, April 29, 2025. The Company will hold a conference call at 12:30 p.m. Eastern Time the same day to discuss the results. A link to the live audio webcast will be provided through the Investor Relations page of the Company’s website at www.investor.lgihomes.com under the Events and Presentations section. An archive of the webcast will be available for replay on the Company’s...

Continue reading

Zefiro Founder and CEO Appears on Orphan and Marginal Wells Panel in Fort Worth, Texas Led by JPMorganChase Head of Operational Decarbonization

The annual event, which is hosted by the Neeley School of Business and was sponsored by JPMorgan and Double Eagle Energy Holdings, provides a forum for leaders across the energy industry to address pressing production and sustainability-related issues FORT LAUDERDALE, Fla., April 03, 2025 (GLOBE NEWSWIRE) — ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) today announced that its Founder and CEO Talal Debs PhD served as a featured speaker at the TCU Global Energy Symposium. The annual conference is hosted by the Neeley School of Business and is an opportunity for energy industry leaders, influencers, and investors to discuss sector trends, share best practices, and forge important commercial connections. This year’s iteration was sponsored by JPMorgan and Double Eagle...

Continue reading

Innospec Schedules First Quarter 2025 Earnings Release and Conference Call

ENGLEWOOD, Colo., April 03, 2025 (GLOBE NEWSWIRE) — Innospec Inc. (NASDAQ: IOSP) today announced that it will release first quarter 2025 earnings results on Thursday, May 8, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Friday, May 9, 2025, at 9:00 a.m. ET. The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal PIN which can be used to join the conference 5-10 minutes prior to the start time. Online Registration Link: https://register-conf.media-server.com/register/BI13f544d76ded4a11b71fa2c2c086f39f An...

Continue reading

Jura Announces Favorable Award on Costs under the Settlement Agreement Arbitration

CALGARY, Alberta, April 03, 2025 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura” or the “Company“) is pleased to announce that it has received a favorable ruling on costs in its International Chamber of Commerce (“ICC”) arbitration proceedings involving Jura’s operating subsidiaries, Spud Energy Pty Limited (“Spud”) and Frontier Holdings Limited (“FHL”) (together the “Claimants”), claiming against Petroleum Exploration (Private) Limited (“PEL”), the operator of the Badin IV North and South blocks (together the “Badin Blocks”). The amount of costs awarded to the Claimants is approximately US$ 0.54 million. PEL is liable to pay the awarded costs to the Claimants on or before June 29, 2025. If any portion of the costs remain unpaid thereafter, such unpaid costs shall accrue interest at the rate of...

Continue reading

Diversified Royalty Corp. Announces April 2025 Cash Dividend

VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) (the “Corporation” or “DIV”) is pleased to announce that its board of directors has approved a cash dividend of $0.02083 per common share for the period of April 1, 2025 to April 30, 2025, which is equal to $0.25 per common share on an annualized basis. The dividend will be paid on April 30, 2025 to shareholders of record as of the close of business on April 15, 2025. About Diversified Royalty Corp. DIV is a multi-royalty corporation, engaged in the business of acquiring top-line royalties from well-managed multi-location businesses and franchisors in North America. DIV’s objective is to acquire predictable, growing royalty streams from a diverse group of multi-location businesses and franchisors. DIV currently owns...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.